Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.
Cancer Med
; 10(13): 4366-4374, 2021 07.
Article
in En
| MEDLINE
| ID: mdl-34057299
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Adenocarcinoma
/
Antineoplastic Combined Chemotherapy Protocols
/
Esophagogastric Junction
Type of study:
Clinical_trials
Limits:
Aged80
Language:
En
Journal:
Cancer Med
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: